Clinical and research issues in neonatal anemia and thrombocytopenia.
OBJECTIVE
Anemia and thrombocytopenia are the most common hematological problems in neonates. Red blood cell (RBC) and platelet transfusions are the mainstays of therapy, but data to guide neonatal transfusion practices have been sparse. Recombinant hematopoietic growth factors represent another therapeutic alternative, but their use in this population requires a solid understanding of the developmental differences between fetal and adult hematopoiesis.


RESULTS
Recently, follow-up studies from children randomized as neonates to either liberal or restrictive RBC transfusion approaches were published. Results of these studies have so far been contradictory and have generated more questions than answers. New developmental stage-specific problems associated with RBC transfusions were also uncovered, such as the transfusion-associated necrotizing enterocolitis. Finally, two thrombopoietin (Tpo) mimetics were approved by the FDA for the treatment of adults with chronic immune thrombocytopenia, thus offering a novel potential therapeutic alternative for thrombocytopenic neonates.


CONCLUSIONS
In this review, we will discuss the currently available data regarding neonatal RBC and platelet transfusion thresholds, as well as the potential limitations, and concerns associated with the use of erythropoietin and Tpo mimetics in this patient population. Finally, we will point out specific areas wherein additional research is critically needed.
Division of Newborn Medicine, Children's Hospital Boston, Boston, Massachusetts, USA.
Hannes
H
Sallmon
Martha
M
Sola-Visner
D000328:Adult; D000751:Anemia, Neonatal / Q000175:diagnosis* / Q000196:embryology / Q000628:therapy; D017707:Erythrocyte Transfusion / Q000639:trends; D005500:Follow-Up Studies; D017408:Guidelines as Topic; D006801:Humans; D007223:Infant; D007231:Infant, Newborn; D010976:Platelet Count; D017713:Platelet Transfusion / Q000639:trends; D016032:Randomized Controlled Trials as Topic; D013921:Thrombocytopenia / Q000175:diagnosis* / Q000453:epidemiology / Q000628:therapy; D013926:Thrombopoietin / Q000097:blood*
D013926:Thrombopoietin